Andrew Evens

academic, CINJ-Radiation Oncology-Clinic

Emailae378@rutgers.edu

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Andrew Evens is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

6 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

1 Active
3 Finished

Determining treatment sensitivity in B cell lymphoma by novel microfluidics-based NK cell immunogenicity platform
Evens, A., HUANG, T. J. & KONRY, T. T.
National Cancer Institute
5/1/18 → 4/30/21
Project: Research project
MAP Kinase Signaling in Lymphoma: A Novel Therapeutic Paradigm
Evens, A., Gartenhaus, R., Gartenhaus, R., EVENS, A. M., GARTENHAUS, R. B., EVENS, A. M. & GARTENHAUS, R. B.
National Cancer Institute
8/10/12 → 8/31/17
Project: Research project
Impact of Lifestyle with Tumor Pathways and Microenvironment on Lymphoma Survival
Evens, A., Chiu, B. C. H., Chiu, B. C. H., Chiu, B. C. H. & EVENS, A. M.
National Cancer Institute
7/17/09 → 12/30/11
Project: Research project
Targeting the Mitochondria to Treat Lymphoma and Myeloma
Evens, A.
National Cancer Institute
6/9/05 → 5/31/10
Project: Research project

9334 Citations
49 h-Index
131 Article
33 Review article
8 Letter
7 Comment/debate
More

Burkitt lymphoma in the modern era: Real-world outcomes and prognostication across 30 US cancer centers
Evens, A. M., Danilov, A., Jagadeesh, D., Sperling, A., Kim, S. H., Vaca, R., Wei, C., Rector, D., Sundaram, S., Reddy, N., Lin, Y., Farooq, U., D'Angelo, C., Bond, D. A., Berg, S., Churnetski, M. C., Godara, A., Khan, N., Choi, Y. K., Yazdy, M. & 38 others, Rabinovich, E., Varma, G., Karmali, R., Mian, A., Savani, M., Burkart, M., Martin, P., Ren, A., Chauhan, A., Diefenbach, C., Straker-Edwards, A., Klein, A. K., Blum, K. A., Boughan, K. M., Smith, S. E., Haverkos, B. M., Orellana-Noia, V. M., Kenkre, V. P., Zayac, A., Ramdial, J., Maliske, S. M., Epperla, N., Venugopal, P., Feldman, T. A., Smith, S. D., Stadnik, A., David, K. A., Naik, S., Lossos, I. S., Lunning, M. A., Caimi, P., Kamdar, M., Palmisiano, N., Bachanova, V., Portell, C. A., Phillips, T., Olszewski, A. J. & Alderuccio, J. P., Jan 21 2021, In: Blood. 137, 3, p. 374-386 13 p.
Research output: Contribution to journal › Article › peer-review
4 Scopus citations
Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphoma
Allen, P. B., Savas, H., Evens, A. M., Advani, R. H., Palmer, B., Pro, B., Karmali, R., Mou, E., Bearden, J., Dillehay, G., Bayer, R. A., Eisner, R. M., Chmiel, J. S., O'Shea, K., Gordon, L. I. & Winter, J. N., Mar 11 2021, In: Blood. 137, 10, p. 1318-1326 9 p.
Research output: Contribution to journal › Article › peer-review
SARS-CoV-2 nosocomial infection: Real-world results of environmental surface testing from a large tertiary cancer center
Shah, M. R., Jan, I., Johns, J., Singh, K., Kumar, P., Belarmino, N., Saggiomo, K. J., Hayes, C., Washington, K., Toppmeyer, D., Haffty, B. G., Libutti, S. & Evens, A. M., 2021, (Accepted/In press) In: Cancer.
Research output: Contribution to journal › Article › peer-review

Open Access
A systematic review of therapeutic regimens for older patients with newly diagnosed Hodgkin lymphoma
Allen, P. B., Ayers, A., Behera, M., Evens, A. M. & Flowers, C., Jun 6 2020, In: Leukemia and Lymphoma. 61, 7, p. 1555-1564 10 p.
Research output: Contribution to journal › Article › peer-review
A three-arm randomized Phase II study of bendamustine/rituximab with bortezomib induction or lenalidomide continuation in untreated follicular lymphoma: ECOG-ACRIN E2408
Evens, A. M., Hong, F., Habermann, T. M., Advani, R. H., Gascoyne, R. D., Witzig, T. E., Quon, A., Ranheim, E. A., Ansell, S. M., Cheema, P. S., Dy, P. A., O'Brien, T. E., Winter, J. N., Cescon, T. P., Chang, J. E. & Kahl, B. S., Sep 2020, In: Clinical Cancer Research. 26, 17, p. 4468-4477 10 p.
Research output: Contribution to journal › Article › peer-review
3 Scopus citations